Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience

BACKGROUND: Chemotherapy with gemcitabine and cisplatin has been the standard of care in first-line chemotherapy for advanced biliary tract cancer (BTC) since the trial ABC-02 was published in 2010. We aimed to investigate the prognostic and predictive factors of this regimen in a cohort of Taiwanes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chiao-En, Chou, Wen-Chi, Hsieh, Chia-Hsun, Chang, John Wen-Cheng, Lin, Cheng-Yu, Yeh, Chun-Nan, Chen, Jen-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227306/
https://www.ncbi.nlm.nih.gov/pubmed/32410631
http://dx.doi.org/10.1186/s12885-020-06914-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227306/
https://www.ncbi.nlm.nih.gov/pubmed/32410631
http://dx.doi.org/10.1186/s12885-020-06914-1

Ejemplares similares